Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of trastuzumab-pkrb plus modified FOLFOX-6 in biliary tract cancer
KCT0004439Phase 2Completed
- Sponsor
- Korean Cancer Study Group
- Start
- Jun 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab-pkrb in biliary cancer, sponsored by Korean Cancer Study Group. Started Jun 2020; status: completed.
02
Drugs
trastuzumab-pkrb
03
Conditions
biliary cancer
Beyond the preview
Go deeper on KCT0004439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004439.